What factors should be considered when determining optimal treatment duration for ixekizumab in patients with psoriasis?

Featuring Raj Chovatiya, MD, PhD, MSCI | Associate Professor, Rosalind Franklin University of Medicine and Science, Chicago Medical School; Founder and Director,Center for Medical Dermatology + Immunology Research,Chicago, IL | Published July 17, 2024